Updated Jul 16, 2026
Griffith Donald J. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Donald J. Griffith is a corporate executive known for his role as Chief Financial Officer and Director at Sonnet BioTherapeutics Holdings, Inc. He has been involved in several SEC filings related to his positions within the company.
| Role | Chief Financial Officer, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 10.4K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 10.0K | — | |
| 2024-12-05 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 317 | — |
Donald J. Griffith is a corporate executive known for his role as Chief Financial Officer and Director at Sonnet BioTherapeutics Holdings, Inc. He has been involved in several SEC filings related to his positions within the company.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Griffith Donald J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.